Drug Pricing, Health Equity and Prescription Digital Therapeutics

Drug Pricing: Four Trends to Keep in Mind

Medicare drug-price negotiation is a big story in?#pharma right now, thanks to the Inflation Reduction Act, but don’t forget these four trends:

1. Agility and flexibility in the rapidly evolving landscape of drug pricing policy are key components of any market access strategy
2. Price increases will not go unnoticed (especially by watchdogs such as ICER) and should be accompanied by well-evidenced justification
3. Anchor pricing strategies on transparency and prepare to have conversations about cost throughout the product lifecycle
4. Rebates, antitrust laws, and patent enforcement are also being targeted through a web of proposed federal and state bills

#marketaccess #drugpricing #healthcare

How can we help you optimize access? Reach out to Dina Steinfurth .

New Episode of The IDI Podcast: Prescription Drug Therapeutics

In the latest episode of The IDI podcast, Christine Castiglione, MPH discusses the opportunities and challenges of #prescriptiondigitaltherapeutics.

"One of the top benefits is that prescription digital therapeutics offers access to treatment at any time," Castiglione says.

For payers, manufacturers and even physicians, one big challenge is deciding whether or not prescription drug therapeutics is a novel benefit. Clarifying PDT's benefit status "will help P&T committees know who the right stakeholders are that need to be at the table when making decisions about products, and then what the payment structure is going to look like," says Castiglione.

Listen to the episode wherever you hear podcasts, or click on this link.

Health Equity: The Hidden Challenge of Data Analytics

Think critically about representation when modeling healthcare data, according to the new health equity white paper Archbow Consulting , Entrée Health and Valuate. Data can unintentionally exacerbate health inequity by:

• Asking the wrong questions to incomplete populations
• Missing upstream socioeconomic determinants of health
• Introducing bias into conclusions from analytical techniques with missing information or biased assumptions in data inputs
• Misinterpreting the results of health equity analyses from marginalized groups

#healthequity #dataanalytics #socialdeterminantsofhealth

Read the white paper here.